论文部分内容阅读
目的:对比分析化疗和放疗在治疗早中期肺癌的优势、价值,以及2种方法存在的不足之处。方法:对380例经手术明确病理诊断的早中期肺癌进行回顾性分析,通过两独立样本T检验的方法比较化疗和放疗两种不同治疗方法的病人1年和5年的存活率状况。结果:在380例早中期肺癌患者中,化疗组190人,1年后存活率51.50%,放疗组190人,1年后存活率为67.21%,经两独立样本T检验,P值为0.012,说明放疗组1年存活率高于化疗组,2组之间差异有统计学意义。化疗组190人,5年后存活率26.12%,放疗组190人,5年后存活率为12.36%,经两独立样本T检验,P值为0.002,说明化疗组5年存活率高于放疗组,2组之间差异有统计学意义。结论:对于早中期肺癌患者来说,早期放疗效果及1年后的存活率放疗优于化疗,而5年后的存活率化疗优于放疗,因此,在临床实践中,应结合患者实际病情,采取不同的治疗方法,以达到最好的治疗效果。
OBJECTIVE: To compare and analyze the advantage and value of chemotherapy and radiotherapy in the treatment of early and mid-stage lung cancer, as well as the shortcomings of the two methods. Methods: A retrospective analysis of 380 early and mid-stage lung cancer diagnosed by surgery was performed. Two-year T-test was used to compare the 1-year and 5-year survival rates of patients undergoing chemotherapy and radiotherapy. Results: Of the 380 patients with early-to-mid-stage lung cancer, there were 190 patients in the chemotherapy group, with a survival rate of 51.50% after 1 year and 190 patients in the radiotherapy group. The survival rate after 1 year was 67.21%. The P value was 0.012 after two independent samples T tests, 1-year radiotherapy group survival rate was higher than the chemotherapy group, the difference between the two groups was statistically significant. The chemotherapy group of 190 patients, 5 years after the survival rate of 26.12%, radiotherapy group of 190 people, 5 years after the survival rate was 12.36%, by two independent samples T test, P value was 0.002, 5-year survival rate of chemotherapy group was higher than radiotherapy group , The difference between the two groups was statistically significant. Conclusion: Early and mid-term lung cancer patients, early radiotherapy and 1 year survival rate after radiotherapy than chemotherapy, and 5 years after the survival rate of chemotherapy is better than radiotherapy, therefore, in clinical practice, patients should be combined with the actual condition, Take a different treatment, in order to achieve the best therapeutic effect.